Gwajin asibiti akan CAR-T Cell far ga marasa lafiya da BCMA/TACI-tabbatacce koma baya da/ko refractory mahara myeloma

Gwajin asibiti a cikin ciwon daji
Wannan hannu ɗaya ne, buɗaɗɗen lakabin, binciken tsakiya guda. Ana nuna wannan binciken don sake dawowa ko BCMA/TACI tabbataccen sake dawowa da/ko mai raɗaɗi mai yawa myeloma. Zaɓuɓɓukan matakan kashi da adadin batutuwa sun dogara ne akan gwajin asibiti na samfuran ƙasashen waje iri ɗaya. Za a yi wa marasa lafiya 36 rajista. Manufar farko ita ce bincika aminci, babban abin la'akari shine aminci mai alaƙa da kashi.

Share Wannan Wallafa

A takaice dai:

Nazarin APRIL Kwayoyin CAR-T ga marasa lafiya tare da BCMA/TACI tabbatacce koma baya da/ko refractory mahara myeloma

Cikakken Bayani:

This is a single arm, open-label, single-center study. This study is indicated for relapsed or refractory BCMA/TACI positive relapsed and/or refractory multiple myeloma. The selection of dose levels and the number of subjects are based on gwaji na asibiti of similar foreign products. 36 patients will be enrolled. The primary objective is to explore safety; the main consideration is dose-related safety.

sharudda

Ka'idodin Hadawa:

  1. An tabbatar da ganewar asali na BCMA/TACI+ Multi myeloma (MM):
    1. Marasa lafiya tare da MM waɗanda suka sake komawa bayan BCMA CAR-T far; Ko MM tare da tabbataccen magana na BCMA/TACI;
    2. Maimaitawa bayan dashen kwayar cutar hematopoietic;
    3. Matsaloli tare da sake dawowa tabbatacce kadan saura cuta;
    4. Rawar da ke da wuyar kawar da ita ta hanyar chemotherapy ko radiotherapy.
  2. Namiji ko mace masu shekaru 18-75;
  3. Jimlar bilirubin ≤ 51 umol/L, ALT da AST ≤ 3 sau na babba iyaka na al'ada, creatinine ≤ 176.8 umol/L;
  4. Echocardiogram yana nuna juzu'in fitarwa na ventricular hagu (LVEF) ≥50%;
  5. Babu kamuwa da cuta mai aiki a cikin huhu, jikewar oxygen na jini a cikin gida shine ≥ 92%;
  6. Ƙayyade lokacin rayuwa ≥ watanni 3;
  7. Matsayin aikin ECOG 0 zuwa 2;
  8. Marasa lafiya ko masu kula da su na doka sun ba da kansu don shiga cikin binciken kuma su sanya hannu kan sanarwar da aka sanar.

Ka'idojin keɓewa:

Abubuwan da ke da kowane ɗayan waɗannan sharuɗɗan keɓance masu zuwa ba su cancanci wannan gwaji ba:

  1. Tarihin raunin craniocerebral, damuwa mai hankali, farfaɗowa, ischemia cerebrovascular, da cerebrovascular, cututtuka na hemorrhagic;
  2. Electrocardiogram yana nuna tsawan lokaci QT, cututtukan zuciya mai tsanani kamar arrhythmia mai tsanani a baya;
  3. Mata masu ciki (ko masu shayarwa);
  4. Marasa lafiya tare da cututtuka masu tsanani (ban da kamuwa da cutar urinary mai sauƙi da pharyngitis na kwayan cuta);
  5. Kamuwa da cuta mai cutar hanta ko cutar hanta ta C;
  6. Jiyya na lokaci-lokaci tare da steroids na tsarin a cikin makonni 2 kafin a gwada, sai dai ga marasa lafiya kwanan nan ko a halin yanzu suna karɓa a cikin kwayoyin halitta;
  7. A baya ana bi da su tare da kowane samfurin tantanin halitta na CAR-T ko wasu hanyoyin maganin ƙwayoyin cuta na T cell;
  8. Creatinine> 2.5 mg / dl, ko ALT / AST> sau 3 na adadin al'ada, ko bilirubin> 2.0 mg / dl;
  9. Sauran cututtuka marasa kulawa waɗanda ba su dace da wannan gwaji ba;
  10. Marasa lafiya masu kamuwa da cutar HIV;
  11. Duk wani yanayi da mai binciken ya yi imani zai iya ƙara haɗarin marasa lafiya ko tsoma baki tare da sakamakon binciken

Biyan kuɗi zuwa ga Newsletter

Sami sabuntawa kuma kada ku rasa bulogi daga Cancerfax

Toarin Don Bincika

Fahimtar Ciwon Sakin Cytokine: Dalilai, Alamu, da Jiyya
CAR T-Cell far

Fahimtar Ciwon Sakin Cytokine: Dalilai, Alamu, da Jiyya

Ciwon Saki na Cytokine (CRS) wani tsarin rigakafi ne wanda sau da yawa ke haifar da wasu jiyya kamar immunotherapy ko CAR-T cell far. Ya ƙunshi yawan sakin cytokines, yana haifar da alamun bayyanar da ke fitowa daga zazzabi da gajiya zuwa rikice-rikice masu haɗari masu haɗari kamar lalacewar gabbai. Gudanarwa yana buƙatar kulawa da hankali da dabarun shiga tsakani.

Matsayin ma'aikatan lafiya a cikin nasarar CAR T Cell therapy
CAR T-Cell far

Matsayin ma'aikatan lafiya a cikin nasarar CAR T Cell therapy

Ma'aikatan jinya suna taka muhimmiyar rawa a cikin nasarar CAR T-cell far ta hanyar tabbatar da kulawar marasa lafiya a duk lokacin aikin jiyya. Suna ba da tallafi mai mahimmanci yayin sufuri, lura da mahimman alamun marasa lafiya, da gudanar da ayyukan gaggawa na likita idan rikitarwa ta taso. Amsar su da sauri da kulawar ƙwararrun suna ba da gudummawa ga amincin gabaɗaya da ingancin jiyya, sauƙaƙe sauye-sauye masu sauƙi tsakanin saitunan kiwon lafiya da haɓaka sakamakon haƙuri a cikin ƙalubalen shimfidar wurare na ci-gaba na salon salula.

Ana buƙatar taimako? Ourungiyarmu a shirye take don taimaka muku.

Muna fatan samun lafiya cikin sauri na masoyinku da na kusa.

Fara hira
Muna Kan layi! Yi Taɗi da Mu!
Duba lambar
Hello,

Barka da zuwa CancerFax!

CancerFax wani dandali ne na majagaba wanda aka keɓe don haɗa mutane da ke fuskantar ciwon daji na zamani tare da hanyoyin kwantar da hankali kamar CAR T-Cell far, TIL far, da gwaji na asibiti a duk duniya.

Bari mu san abin da za mu iya yi muku.

1) Maganin ciwon daji a kasashen waje?
2) CAR T-Cell far
3) rigakafin cutar daji
4) Shawarar bidiyo ta kan layi
5) Maganin Proton